Inventor · disambiguated record
Chong Hak Chae
Also filed as: CHAE CHONG HAK
6 granted patents·9 pending applications·11 citations·filing 2015–2024
71Inventor score
Files withKOREA RES INST CHEMICAL TECH8RESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV3KOREA RES INST CHEM TECH1KOREA RESERARCH INSTITUTE OF CHEMICAL TECH1UNIV SUNGKYUNKWAN RES & BUS1
Top patents by PatentIndex Score
15 records- 0192US9199944B2N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancerKOREA RES INST CHEM TECH·Filed 2015·Granted Dec 1, 2015·10 cites·11 claims
- 0279US2024352067A1Pyrrolidine carboxamido derivatives and methods for preparing and using the sameRESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV·Filed 2024·Application pending·0 cites
- 0373US2023018246A1Pyrrolidine carboxamido derivatives and methods for preparing and using the sameRESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV·Filed 2022·Application pending·0 cites
- 0463US10053458B2Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredientKOREA RES INST CHEMICAL TECH·Filed 2015·Granted Aug 21, 2018·1 cites·10 claims
- 0561US11365215B2Method for preventing, improving, or treating inflammatory bowel diseaseRESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV·Filed 2018·Granted Jun 21, 2022·0 cites·16 claims
- 0658US2025145625A1Pyrazolopyrimidine derivative and anticancer pharmaceutical composition containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2022·Application pending·0 cites
- 0757US2022249482A1N2,n4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancerKOREA RES INST CHEMICAL TECH·Filed 2022·Application pending·0 cites
- 0855US2017008924A1Pyrrolidine carboxamido derivatives and methods for preparing and using the sameUNIV SUNGKYUNKWAN RES & BUS·Filed 2016·Application pending·0 cites
- 0954US2025171416A2Novel pyrimidine-2,4-diamine derivatives, preparation method therefor, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancerKOREA RES INST CHEMICAL TECH·Filed 2022·Application pending·0 cites
- 1051US11253516B2N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancerKOREA RES INST CHEMICAL TECH·Filed 2018·Granted Feb 22, 2022·0 cites·20 claims
- 1151US2024343694A1Pyrimidine derivative, method for preparing same, and pharmaceutical composition for preventing or treating cancer comprising same as active ingredientKOREA RESERARCH INSTITUTE OF CHEMICAL TECH·Filed 2022·Application pending·0 cites
- 1249US2022281817A1Benzamide derivative, preparation method therefor, and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancerKOREA RES INST CHEMICAL TECH·Filed 2020·Application pending·0 cites
- 1347US2024254103A9Novel pyrimidine derivative, and composition for preventing or treating neurodegenerative diseases and cancer, comprising sameWHAN IN PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1435US10369149B24-(2-amino-tetrahydronaphthalenyl)pyrimidine derivative, preparation method therefor, and pharmaceutical composition for preventing or treating cancer, containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2015·Granted Aug 6, 2019·0 cites·9 claims
- 1535US10100019B2N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2016·Granted Oct 16, 2018·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Chong Hak Chae files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →